Clinical evaluation of phenserine tartrate extended controlled release tablet (ECRT) formulation in early mild alzheimer's disease and mild to moderate traumatic brain injury.
Ended Awarded Last action
- Contract number
- 75N95024F00001
- Awardee
-
University Of Exeter UEI ZNQ1VJLJQ827
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,242,771
Award facts
- Contract value 100% obligated
- $1,242,770.65 Current and potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- Funding agency
- National Institute on Aging National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541990 All Other Professional, Scientific, and Technical Services
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost No Fee
- Place of performance
- Great Britain, United Kingdom
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | $280,285 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $962,486 |
About this award
The National Institute on Aging issued a delivery order to the University of Exeter on February 1, 2024, for clinical evaluation of Phenserine tartrate extended-release tablet formulation in early mild Alzheimer's disease and mild to moderate traumatic brain injury, with a ceiling value of $1.24 million.
The order is issued under a single-award indefinite delivery contract with the National Institute on Aging valued at $1.99 million over a 30-month period, enabling the agency to task Exeter for clinical evaluation services related to Alzheimer's disease and traumatic brain injury research. Place of performance is Great Britain, United Kingdom. The order carries a Cost No Fee pricing structure and has an ultimate completion date of September 25, 2026. Work includes conducting clinical trials, performing brain imaging and cognitive assessments, and analyzing biomarkers to evaluate the pharmacology of the investigational treatment.
Quick answers
Who was awarded contract 75N95024F00001?
75N95024F00001 was awarded to University Of Exeter by National Institute on Drug Abuse (National Institutes of Health) on February 1, 2024.
How much is contract 75N95024F00001 worth?
The government has obligated $1,242,771 on 75N95024F00001.
Which agency awarded contract 75N95024F00001?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95024F00001, with funding from National Institute on Aging (National Institutes of Health).
Is contract 75N95024F00001 an order under another contract?
Yes. 75N95024F00001 is a delivery order under 75N95024D00002, an indefinite delivery contract.
Was contract 75N95024F00001 competed?
The extent of competition for 75N95024F00001 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award